A.R.T. Advisors’s Thermo Fisher Scientific TMO Stock Holding History

A.R.T. Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,397	Closed	-$4.03M	–	908
2019 Q4	$4.03M	Buy	+12,397	New	+$3.76M	0.2%	118
2019 Q3	–	Sell	-30,997	Closed	-$9.1M	–	1732
2019 Q2	$9.1M	Buy	+30,997	New	+$8.54M	0.52%	22
2019 Q1	–	Sell	-20,600	Closed	-$4.61M	–	1619
2018 Q4	$4.61M	Buy	20,600 +7,700	+60%	+$1.81M	0.3%	58
2018 Q3	$3.15M	Sell	12,900 -23,000	-64%	-$5.29M	0.14%	186
2018 Q2	$7.44M	Buy	35,900 +20,600	+135%	+$4.37M	0.3%	58
2018 Q1	$3.16M	Buy	+15,300	New	+$3.21M	0.13%	229
2017 Q3	–	Sell	-9,200	Closed	-$1.6M	–	1664
2017 Q2	$1.6M	Buy	+9,200	New	+$1.55M	0.09%	335
2016 Q3	–	Sell	-6,455	Closed	-$953K	–	1140
2016 Q2	$953K	Buy	+6,455	New	+$953K	0.05%	565
2015 Q1	–	Sell	-28,081	Closed	-$3.52M	–	1686
2014 Q4	$3.52M	Sell	28,081 -14,401	-34%	-$1.75M	0.13%	205
2014 Q3	$5.17M	Buy	42,482 +10,395	+32%	+$1.26M	0.24%	99
2014 Q2	$3.79M	Buy	32,087 +28,335	+755%	+$3.33M	0.2%	122
2014 Q1	$451K	Buy	+3,752	New	+$446K	0.02%	792
2013 Q4	–	Sell	-7,460	Closed	-$687K	–	1513
2013 Q3	$687K	Buy	+7,460	New	+$675K	0.04%	642

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

A.R.T. Advisors's TMO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 12,397 shares — an estimated $4.03M sold.

A.R.T. Advisors first reported a position in TMO in Q3 2013 and held it in 13 quarters. The position peaked at $9.1M in Q2 2019. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

A.R.T. Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 12,397 Thermo Fisher Scientific shares in Q1 2020, an estimated $4.03M.
A.R.T. Advisors first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 13 quarters.
A.R.T. Advisors's Thermo Fisher Scientific position peaked at $9.1M in Q2 2019.
1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.